ArticleFrontiers in oncology2026

Impact of 1q vulnerabilities in patients treated with anti-CD38 monoclonal antibodies.

María Sánchez-Tabernero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.